Overall, we estimate that of the $1.08 billion in total Part D spend on this drug, only $434 million was for the drug – the remaining $648 million went to the supply chain.

2016 PART D SPENDING ON ARIPIPRAZOLE

NADAC

Ing. Cost ($434M)

Markup ($648M)
— Read on www.46brooklyn.com/research/2019/3/20/d-is-for-distortion

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.